Business Strategy

After carefully considering its promise and consulting with experts, Independence Blue Cross this year became the first major insurer to provide coverage for certain members who are seeking access to whole genome sequencing.

Health plans are using advanced analytics to improve physician engagement,performance and satisfaction in ACOs and risk-sharing contracts.

Drugs will be provided to health plan members on clinical trials free of charge.

A recent survey suggests suggest a lack of access to appropriate commercial payer arrangements is causing health systems to explore alternatives.

Consumers are demanding transparency in the prices of drugs. Here’s how they are getting it.

Do copay assistance program offer a long-term solution for patients? Experts weigh in.

Cancer care has made great strides in the U.S., but effective care is still too expensive and inaccessible for many Americans. Now, payers and providers at Highmark, Allegheny Health Network and Johns Hopkins are launching a new model that could change cancer collaboration.

A new cancer database, the Genomic Data Commons, aims to make research more accessible

We asked executives how they feel about the future of healthcare. Here’s what they said.

A new Commonwealth Fund study explores cost-sharing reduction plans and marketplace coverage.

Payers have a direct interest in preserving independent physician practices andhelping all physicians regain the Joy of Medicine.

Advances in technology are creating new opportunities for health insurers to move beyond the role of payer to trusted partner in the protection and extension of our health and independence as we age.

The advantages of using an advanced clinical decision support system fall into four general “reducing” categories. Here they are.

It’s time for stakeholders to cooperate in order to limit the wasted spending on prescription medications and chart a path to collectively improving value derivation.

Consumers want more, and it’s time to deliver. Here’s how health insurers can retain current members and attract new ones.

It’s time to step back and assess how the election could impact the managed care industry.

Analysis from Prime shows that improvements in persistency, adherence is key in RA treatments.

Approvals of specialty pharmaceuticals have far outpaced traditional drugs, and that trend will continue. But that’s not the only specialty medication trend that healthcare executives should have on their radar.

Understanding both candidates proposals can help executives make informed decisions.

Here are the top 10 states that deliver the best healthcare services, according to personal-finance website WalletHub.

An independent study considers the global adoption of value-based healthcare across 25 countries.

Five key areas of healthcare, the candidates’ proposals for them, and analysis from experts.

Humana and UCS study shows prevalence of ageism in film and the power of embracing a healthy mindset for healthy aging

Migration to high-deductible plans partly responsible, according to Kaiser Family Foundation survey.

When is retail right? Consider these four benefits that will impact the bottom line.

HHS finalized ClinicalTrial.gov rules encourage healthcare improvement and public benefit by increasing transparency and accountability across the industry.

Why today’s models will always be interim ones-andhow the consumerization of healthcare will drive change.

Expert offers specific actions for managed care execs to take

Industry leaders share who they call when they need advice.

Two fertility experts detail the pros and cons of a fertility benefit plan.